Search
for
Sort by
Research 211–240 of 1000+
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- Understanding sex and gender disparities in COVID-19 mortality: a narrative review beyond biology
- Beau’s Lines and COVID-19; A Systematic Review on Their Association
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches
- Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study
- Dermatological manifestations of COVID-19 and its therapies: a review
- ANDROGENŲ IR ANDROGENINĖS ALOPECIJOS RYŠYS SU COVID-19 INFEKCIJA
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Role of ACE2 polymorphism in COVID-19: impact of age
- The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series
- Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
- Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study
- Dermatological Manifestations of Patients with COVID 19: A Cross-sectional study
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Manifestaciones dermatológicas asociadas a la gravedad de la infección por COVID-19. Estudio observacional transversal retrospectivo de 144 pacientes